Clinical Trial Update: Evaluate the Safety and Efficacy of Caspofungin Acetate as Empirical Therapy in Chinese Adults With Persistent Fever and Neutropenia (0991-055) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating caspofungin acetate as empirical therapy in Chinese adults with persistent fever and neutropenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fungal Infection

Drugs mentioned

• Cancidas (caspofungin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Fungal Infection | Phase 3 | Status: COMPLETED